Expressions of interest open for type 1 diabetes clinical trial proposals

Expressions of interest open for type 1 diabetes clinical trial proposals

JDRF Australia is seeking expressions of interest for type 1 diabetes (T1D) clinical trials focused on targeted therapies.

The request for applications (RFA) will support clinical trials that are key to advancing the field of immunotherapies and other disease modifying therapies and have the capacity to improve the lives of individuals living with T1D at each disease stage.

The RFA aims to increase the number of local clinical trials and enable Australia’s participation as an international clinical trial site, and is open to both Australian and international investigators.

You can download the RFA here.

Applications are to be submitted online using the online grants management system RMS360. For instructions on how to use RMS360, click here.

KEY DATES

This is an open call with the opportunity to submit applications at any time during the year.

Funding decisions will be announced twice a year in April and December.

Apply here.